Hyperhomocysteinemia and cardiovascular diseases.
Guieu R, Ruf J, Mottola G.
Ann Biol Clin (Paris). 2022 Feb 1;80(1):7-14. doi: 10.1684/abc.2021.1694.
Hyperhomocysteinemia in Cardiovascular Diseases: Revisiting Observational Studies and Clinical Trials.
Guéant JL, Guéant-Rodriguez RM, Oussalah A, Zuily S, Rosenberg I.
Thromb Haemost. 2023 Mar;123(3):270-282. doi: 10.1055/a-1952-1946. Epub 2022 Sep 28.
Hyperhomocysteinemia is an emerging comorbidity in ischemic stroke.
Poddar R.
Exp Neurol. 2021 Feb;336:113541. doi: 10.1016/j.expneurol.2020.113541. Epub 2020 Dec 3.
Hyperhomocysteinemia and thrombosis.
Cattaneo M.
Lipids. 2001;36 Suppl:S13-26. doi: 10.1007/s11745-001-0677-9.
Hyperhomocysteinemia and cardiovascular disease in animal model.
Azad MAK, Huang P, Liu G, Ren W, Teklebrh T, Yan W, Zhou X, Yin Y.
Amino Acids. 2018 Jan;50(1):3-9. doi: 10.1007/s00726-017-2503-5. Epub 2017 Oct 10.
Causes of hyperhomocysteinemia and its pathological significance.
Kim J, Kim H, Roh H, Kwon Y.
Arch Pharm Res. 2018 Apr;41(4):372-383. doi: 10.1007/s12272-018-1016-4. Epub 2018 Mar 19.
Hyperhomocysteinemia: Impact on Neurodegenerative Diseases.
Sharma M, Tiwari M, Tiwari RK.
Basic Clin Pharmacol Toxicol. 2015 Nov;117(5):287-96. doi: 10.1111/bcpt.12424. Epub 2015 Jun 19.
Hyperhomocysteinemia and venous thromboembolism.
Cattaneo M.
Semin Thromb Hemost. 2006 Oct;32(7):716-23. doi: 10.1055/s-2006-951456.
Hyperhomocysteinemia: Focus on Endothelial Damage as a Cause of Erectile Dysfunction.
Salvio G, Ciarloni A, Cutini M, Balercia G.
Int J Mol Sci. 2021 Jan 3;22(1):418. doi: 10.3390/ijms22010418.
Hyperhomocysteinemia and immune activation.
Schroecksnadel K, Frick B, Winkler C, Leblhuber F, Wirleitner B, Fuchs D.
Clin Chem Lab Med. 2003 Nov;41(11):1438-43. doi: 10.1515/CCLM.2003.221.
